209 related articles for article (PubMed ID: 7734209)
21. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Cote GJ; Wohllk N; Evans D; Goepfert H; Gagel RF
Baillieres Clin Endocrinol Metab; 1995 Jul; 9(3):609-30. PubMed ID: 7575334
[TBL] [Abstract][Full Text] [Related]
22. De novo RET proto-oncogene mutation in a patient with multiple endocrine neoplasia type 2B.
Chang TJ; Wu SL; Chang TC; Huang SH; Chang TJ
J Formos Med Assoc; 1999 Oct; 98(10):692-7. PubMed ID: 10575840
[TBL] [Abstract][Full Text] [Related]
23. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
Heshmati HM; Hofbauer LC
Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
[No Abstract] [Full Text] [Related]
24. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
Acton DS; Velthuyzen D; Lips CJ; Höppener JW
Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
[TBL] [Abstract][Full Text] [Related]
25. Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.
Frilling A; Höppner W; Eng C; Mulligan L; Raue F; Broelsch CE
J Mol Med (Berl); 1995 May; 73(5):229-33. PubMed ID: 7670926
[TBL] [Abstract][Full Text] [Related]
26. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.
Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
J Intern Med; 1998 Jun; 243(6):509-13. PubMed ID: 9681851
[TBL] [Abstract][Full Text] [Related]
28. Lessons learned from the management of a rare genetic cancer.
Cote GJ; Gagel RF
N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
[No Abstract] [Full Text] [Related]
29. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
[TBL] [Abstract][Full Text] [Related]
30. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
Wiench M; Kwaśniewski M; Gubała E; Wygoda Z; Pawlaczek A; Oczko M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():415-21. PubMed ID: 12182058
[TBL] [Abstract][Full Text] [Related]
31. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
Kameyama K; Okinaga H; Takami H
Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the RET proto-oncogene in medullary thyroid carcinoma.
Höppner W
Clin Lab; 2007; 53(5-6):283-4. PubMed ID: 17605402
[No Abstract] [Full Text] [Related]
33. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
34. Multiple endocrine neoplasia types 1 and 2.
Ellard S
Methods Mol Med; 2004; 92():267-83. PubMed ID: 14733317
[No Abstract] [Full Text] [Related]
35. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Takami H
Endocr Pathol; 2003; 14(2):123-31. PubMed ID: 12858002
[TBL] [Abstract][Full Text] [Related]
37. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.
Matias-Guiu X; Garrastazu MT
Histopathology; 1998 Mar; 32(3):281-2. PubMed ID: 9568520
[No Abstract] [Full Text] [Related]
38. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and therapy of medullary thyroid carcinoma].
Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
[No Abstract] [Full Text] [Related]
40. Multiple endocrine neoplasia type 2B.
Nakata S; Okugi H; Saitoh Y; Takahashi H; Shimizu K
Int J Urol; 2001 Jul; 8(7):398-400. PubMed ID: 11442663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
